bromodeoxyuridine has been researched along with Acrocephalosyndactylia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basilico, C; Bellosta, P; Mansukhani, A; Sahni, M | 1 |
1 other study(ies) available for bromodeoxyuridine and Acrocephalosyndactylia
Article | Year |
---|---|
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Topics: Acrocephalosyndactylia; Alkaline Phosphatase; Animals; Apoptosis; Bromodeoxyuridine; Calcification, Physiologic; Cell Differentiation; Cell Division; Cell Line; Craniofacial Dysostosis; DNA Fragmentation; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Histocytochemistry; Mice; Mice, Transgenic; Osteoblasts; Point Mutation; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Signal Transduction; Transfection | 2000 |